AzTrials
AzTrials

Postoperative Pain, AcuteNCT07743736

Aromatherapy and Massage After Cesarean Delivery

A study testing Aromatherapy Inhalation and Aromatherapy-Assisted Back Massage in people with Postoperative Pain, Acute and Anxiety, Postpartum, run by Uşak University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cesarean delivery is a common surgical procedure associated with postoperative pain, anxiety, and reduced maternal comfort during the early postpartum period. Non-pharmacological interventions such as aromatherapy and massage have been suggested as supportive approaches for improving maternal well-being; however… Read more about this study

Who is it for?
Ages 18 to 40 years, women only
What is being tested?
Aromatherapy Inhalation and Aromatherapy-Assisted Back Massage
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
23 Feb 2026to 31 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Women aged 18-40 years Primiparous women Undergoing cesarean delivery under spinal anesthesia Term pregnancy (38-42 gestational weeks) Able to communicate and complete study questionnaires Willing to participate and provide written informed consent No known allergy to essential oils Intact sense of smell

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Usak University Training and Research Hospital

    Uşak, Uşak, 64200

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Aromatherapy and Massage on Pain, Anxiety, and Comfort After Cesarean Delivery: A Randomized Controlled Trial

Cesarean delivery is a common surgical procedure associated with postoperative pain, anxiety, and reduced maternal comfort during the early postpartum period. Non-pharmacological interventions such as aromatherapy and massage have been suggested as supportive approaches for improving maternal well-being; however, further evidence is needed regarding their effectiveness after cesarean delivery.

This randomized controlled trial aims to evaluate the effects of aromatherapy inhalation and aromatherapy-assisted back massage on postoperative pain, anxiety, and postpartum comfort in women after cesarean delivery.

Read more

Participants who meet the eligibility criteria will be randomly assigned to three groups: an aromatherapy inhalation group, an aromatherapy-assisted back massage group, and a placebo group receiving sterile water inhalation as a simulation. Interventions will be initiated after cesarean delivery, and outcomes will be assessed using the Visual Analog Scale for pain intensity, the State-Trait Anxiety Inventory for anxiety level, and the Postpartum Comfort Scale for comfort level.

This study is expected to provide information about the potential contribution of complementary non-pharmacological interventions to maternal recovery after cesarean delivery.

Read the detailed description

Cesarean delivery is one of the most frequently performed surgical procedures worldwide and is commonly associated with postoperative pain, anxiety, and decreased maternal comfort during the early postpartum period. Effective management of these symptoms is important for maternal recovery, early mobilization, breastfeeding, and overall postpartum well-being.

Pharmacological approaches are commonly used for postoperative symptom management; however, interest in complementary non-pharmacological interventions has increased due to their potential supportive effects and ease of application. Aromatherapy and massage are among the approaches used to promote relaxation, reduce perceived discomfort, and improve psychological well-being.

This randomized controlled trial was designed to investigate the effects of aromatherapy-based interventions on postoperative recovery outcomes among women after cesarean delivery. The study compares aromatherapy inhalation, aromatherapy-assisted massage, and placebo conditions to evaluate their potential effects on maternal pain, anxiety, and comfort during the early postoperative period.

The results of this study may contribute to the evidence regarding the use of complementary supportive interventions in postpartum care following cesarean delivery.

Being tested
Aromatherapy Inhalation, Aromatherapy-Assisted Back Massage, placebo inhalation
Keywords
cesarean delivery, postoperative pain, Aromatherapy, Postpartum comfort, Randomized controlled trial, Anxiety
Medical subject headings
Pain, Postoperative, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aromatherapy InhalationBehavioural

    Participants will receive aromatherapy inhalation using Rosa damascena essential oil beginning at the 6th postoperative hour after cesarean delivery. For each session, 2 drops of Rosa damascena essential oil will be applied to a sterile gauze and held approximately 10 cm from the participant's nose. Participants will breathe normally during the inhalation period. The intervention will be performed at 6, 18, 30, and 42 hours after surgery, with each session lasting 10 minutes.

  • Aromatherapy-Assisted Back MassageBehavioural

    Participants will receive aromatherapy-assisted back massage beginning at the 6th postoperative hour after cesarean delivery. The massage will be applied to the upper and lower back regions using Rosa damascena essential oil diluted to 3% with sweet almond carrier oil. The intervention will be performed at 6, 18, 30, and 42 hours after surgery according to the study protocol. Participants will be positioned in a comfortable lateral or sitting position during the massage application.

  • placebo inhalationBehavioural

    Participants will receive placebo inhalation using sterile water as a simulation of aromatherapy. The intervention will begin at the 6th postoperative hour after cesarean delivery and will be administered at 6, 18, 30, and 42 hours after surgery. Each session will follow the same procedure and duration as the aromatherapy inhalation group according to the study protocol.

Study groups in NCT07743736
Study groupRoleWhat they receive
Aromatherapy Inhalation GroupExperimentalParticipants in this group will receive aromatherapy inhalation beginning at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery using Rosa damascena essential oil according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after the intervention sessions according to the study protocol.
Receives: Behavioral: Aromatherapy Inhalation
Aromatherapy-Assisted Back Massage GroupExperimentalParticipants in this group will receive aromatherapy-assisted back massage starting at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery. Back massage will be performed using Rosa damascena essential oil diluted with a carrier oil according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after each intervention session.
Receives: Behavioral: Aromatherapy-Assisted Back Massage
Placebo GroupPlacebo comparatorParticipants in this group will receive placebo inhalation beginning at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery using sterile water as a simulation of aromatherapy according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after the intervention sessions according to the study protocol.
Receives: Behavioral: placebo inhalation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain intensity

    Pain intensity will be assessed using the Visual Analog Scale (VAS), a 0-10 scale in which higher scores indicate greater pain intensity.

    Measured: From 6 to 42 hours after cesarean delivery (before and after each intervention session)

Secondary outcomes (2)
  1. Anxiety level

    Anxiety level will be assessed using the State-Trait Anxiety Inventory (STAI), including the State Anxiety and Trait Anxiety subscales. Higher scores indicate higher anxiety levels.

    Measured: Before the first intervention session and after the final intervention session (42 hours after cesarean delivery).

  2. Postpartum comfort level

    Postpartum comfort level will be assessed using the Postpartum Comfort Scale. The scale evaluates physical, sociocultural, and psychospiritual comfort dimensions. Higher scores indicate higher postpartum comfort levels.

    Measured: Before the first intervention session and after the final intervention session (42 hours after cesarean delivery).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2026
  2. Study start23 Feb 2026
  3. Primary completion31 Jul 2026
  4. Study completion31 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of three parallel groups: aromatherapy inhalation, aromatherapy-assisted back massage, or placebo group. Outcomes will be compared between groups after the intervention period.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07743736
Sponsor's protocol ID
958-958-26
Status last verified
Aug 2026
First submitted
29 Jul 2026
Last updated
1 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Aromatherapy Inhalation and Aromatherapy-Assisted Back Massage in people with Postoperative Pain, Acute and Anxiety, Postpartum, run by Uşak University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain intensity (time frame: From 6 to 42 hours after cesarean delivery (before and after each intervention session)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in